GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human MYT1 kinase domain (de-phosphorylated) in complex with saracatinib

Analyse Crystal structure of human MYT1 kinase domain (de-phosphorylated) in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VD3
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Membrane-associated tyrosine- and threonine-specific CDC2- inhibitory kinase
EC
2.7.11.1
UniProt
Q99640
Ligands
H8H
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMembrane-associated tyrosine- and threonine-specific CDC2- inhibitory kinase (EC 2.7.11.1)protein29337% helix, 17% strandQ99640

Ligands and binding sites

  • H8H · N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14200.680.8040H8H, EDO
21760.450.7521empty

Compared structures

  • 5VD3 · CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (de-phosphorylated) IN COMPLEX WITH… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99640 · AlphaFold monomer V2.0 prediction for membrane-associated tyrosine- and… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.